Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 1
1983 1
1987 1
1990 2
1991 3
1993 4
1994 1
1995 1
1996 3
1997 8
1998 5
1999 14
2000 6
2001 15
2002 12
2003 14
2004 21
2005 25
2006 26
2007 34
2008 30
2009 30
2010 33
2011 40
2012 48
2013 77
2014 66
2015 60
2016 35
2017 38
2018 46
2019 43
2020 35
2021 45
2022 31
2023 21
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

792 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Colorectal cancer, susceptibility to, 1"
Page 1
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr. Le DT, et al. N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30. N Engl J Med. 2015. PMID: 26028255 Free PMC article. Clinical Trial.
The median progression-free survival and overall survival were not reached in the cohort with mismatch repair-deficient colorectal cancer but were 2.2 and 5.0 months, respectively, in the cohort with mismatch repair-proficient colorectal cancer (hazard …
The median progression-free survival and overall survival were not reached in the cohort with mismatch repair-deficient colorectal …
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.
Zhu G, Pei L, Xia H, Tang Q, Bi F. Zhu G, et al. Mol Cancer. 2021 Nov 6;20(1):143. doi: 10.1186/s12943-021-01441-4. Mol Cancer. 2021. PMID: 34742312 Free PMC article. Review.
Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. ...Patients whose CRC harbors KRAS mutations have a dismal prognosis. Currently, KRAS mutation testing is a routine clinical practice before treating metastatic ca …
Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. ...Patients whose CRC harbors …
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis.
Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, Berndt SI, Timothy Bishop D, Brenner H, Buchanan DD, Bueno-de-Mesquita B, Campbell PT, Castellví-Bel S, Chan AT, Chang-Claude J, Ellingjord-Dale M, Figueiredo JC, Gallinger SJ, Giles GG, Giovannucci E, Gruber SB, Gsur A, Hampe J, Hampel H, Harlid S, Harrison TA, Hoffmeister M, Hopper JL, Hsu L, María Huerta J, Huyghe JR, Jenkins MA, Keku TO, Kühn T, La Vecchia C, Le Marchand L, Li CI, Li L, Lindblom A, Lindor NM, Lynch B, Markowitz SD, Masala G, May AM, Milne R, Monninkhof E, Moreno L, Moreno V, Newcomb PA, Offit K, Perduca V, Pharoah PDP, Platz EA, Potter JD, Rennert G, Riboli E, Sánchez MJ, Schmit SL, Schoen RE, Severi G, Sieri S, Slattery ML, Song M, Tangen CM, Thibodeau SN, Travis RC, Trichopoulou A, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Vodicka P, White E, Wolk A, Woods MO, Wu AH, Peters U, Gunter MJ, Murphy N. Papadimitriou N, et al. Nat Commun. 2020 Jan 30;11(1):597. doi: 10.1038/s41467-020-14389-8. Nat Commun. 2020. PMID: 32001714 Free PMC article.
Physical activity has been associated with lower risks of breast and colorectal cancer in epidemiological studies; however, it is unknown if these associations are causal or confounded. ...We found similar magnitude inverse associations for estrogen positive (ER(+ve …
Physical activity has been associated with lower risks of breast and colorectal cancer in epidemiological studies; however, it …
Multitarget stool DNA testing for colorectal-cancer screening.
Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Imperiale TF, et al. N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19. N Engl J Med. 2014. PMID: 24645800 Free article. Clinical Trial.
BACKGROUND: An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. METHODS: We compared a noninvasive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for colorectal cancer …
BACKGROUND: An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening. METHODS: We compared …
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.
Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, Castellví-Bel S, Chan AT, Chang-Claude J, Cross AJ, de la Chapelle A, Figueiredo JC, Gallinger SJ, Gapstur SM, Giles GG, Gruber SB, Gsur A, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Jenkins MA, Joshu CE, Keku TO, Kühn T, Kweon SS, Le Marchand L, Li CI, Li L, Lindblom A, Martín V, May AM, Milne RL, Moreno V, Newcomb PA, Offit K, Ogino S, Phipps AI, Platz EA, Potter JD, Qu C, Quirós JR, Rennert G, Riboli E, Sakoda LC, Schafmayer C, Schoen RE, Slattery ML, Tangen CM, Tsilidis KK, Ulrich CM, van Duijnhoven FJB, van Guelpen B, Visvanathan K, Vodicka P, Vodickova L, Wang H, White E, Wolk A, Woods MO, Wu AH, Campbell PT, Zheng W, Peters U, Vincent EE, Gunter MJ. Bull CJ, et al. BMC Med. 2020 Dec 17;18(1):396. doi: 10.1186/s12916-020-01855-9. BMC Med. 2020. PMID: 33327948 Free PMC article.
BACKGROUND: Higher adiposity increases the risk of colorectal cancer (CRC), but whether this relationship varies by anatomical sub-site or by sex is unclear. ...Genetic variants from genome-wide association studies of body mass index (BMI) and waist-to-hip ratio (WH …
BACKGROUND: Higher adiposity increases the risk of colorectal cancer (CRC), but whether this relationship varies by anatomical …
Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F. Bai Z, et al. Front Immunol. 2022 Jan 14;12:808964. doi: 10.3389/fimmu.2021.808964. eCollection 2021. Front Immunol. 2022. PMID: 35095898 Free PMC article. Review.
The clinical success of immunotherapy has revolutionized the treatment of cancer patients, bringing renewed attention to tumor-infiltrating lymphocytes (TILs) of various cancer types. Immune checkpoint blockade is effective in patients with mismatched repair …
The clinical success of immunotherapy has revolutionized the treatment of cancer patients, bringing renewed attention to tumor …
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.
Kasprzak A. Kasprzak A. Int J Mol Sci. 2021 Jun 16;22(12):6434. doi: 10.3390/ijms22126434. Int J Mol Sci. 2021. PMID: 34208601 Free PMC article. Review.
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. ...High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase …
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative …
Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis.
Zhou X, Wang L, Xiao J, Sun J, Yu L, Zhang H, Meng X, Yuan S, Timofeeva M, Law PJ, Houlston RS, Ding K, Dunlop MG, Theodoratou E, Li X. Zhou X, et al. Int J Cancer. 2022 Jul 1;151(1):83-94. doi: 10.1002/ijc.33945. Epub 2022 Jan 31. Int J Cancer. 2022. PMID: 35102554 Free PMC article.
Alcohol consumption is thought to be one of the modifiable risk factors for colorectal cancer (CRC). However, the causality and mechanisms by which alcohol exerts its carcinogenic effect are unclear. ...We additionally performed gene-alcohol interaction analysis nes …
Alcohol consumption is thought to be one of the modifiable risk factors for colorectal cancer (CRC). However, the causality an …
Body mass index and colorectal cancer risk: A Mendelian randomization study.
Suzuki S, Goto A, Nakatochi M, Narita A, Yamaji T, Sawada N, Katagiri R, Iwagami M, Hanyuda A, Hachiya T, Sutoh Y, Oze I, Koyanagi YN, Kasugai Y, Taniyama Y, Ito H, Ikezaki H, Nishida Y, Tamura T, Mikami H, Takezaki T, Suzuki S, Ozaki E, Kuriki K, Takashima N, Arisawa K, Takeuchi K, Tanno K, Shimizu A, Tamiya G, Hozawa A, Kinoshita K, Wakai K, Sasaki M, Yamamoto M, Matsuo K, Tsugane S, Iwasaki M. Suzuki S, et al. Cancer Sci. 2021 Apr;112(4):1579-1588. doi: 10.1111/cas.14824. Epub 2021 Feb 25. Cancer Sci. 2021. PMID: 33506574 Free PMC article.
Traditional observational studies have reported a positive association between higher body mass index (BMI) and the risk of colorectal cancer (CRC). However, evidence from other approaches to pursue the causal relationship between BMI and CRC is sparse. ...For the a …
Traditional observational studies have reported a positive association between higher body mass index (BMI) and the risk of colorectal …
Causal relationship of sugar-sweetened and sweet beverages with colorectal cancer: a Mendelian randomization study.
Liu C, Zheng S, Gao H, Yuan X, Zhang Z, Xie J, Yu C, Xu L. Liu C, et al. Eur J Nutr. 2023 Feb;62(1):379-383. doi: 10.1007/s00394-022-02993-x. Epub 2022 Aug 30. Eur J Nutr. 2023. PMID: 36040623
BACKGROUND AND AIM: Prospective cohort studies have suggested that sugar-sweetened beverages (SSBs) intake is significantly associated with the risk of colorectal cancer (CRC). However, it remains unclear whether this observed association was susceptible to p …
BACKGROUND AND AIM: Prospective cohort studies have suggested that sugar-sweetened beverages (SSBs) intake is significantly associated with …
792 results